BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Eiko Lifesciences Ltd. Share Price

NSE
BSE

BSE : 540204

Sector : Chemicals

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

High

Price Summary

Previous Close ₹49.67
Day's Range ₹49.52 - ₹49.95
Open ₹49.76
52 Week Range ₹45.90 - ₹64.44
Volume 378
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 0.19
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 15.85
TTM EPS (₹) 3.13
P/E Ratio 34.20
Book Value(₹) 1.10
PAT Margin (%) 6.16
Face Value (₹) 10.00
ROCE(%) 10.08

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 376.64 70.92
Expenses N/A N/A
PBT 30.64 11.96
Operating profit 0.0 0.0
Net profit 23.19 9.01

Shareholding Pattern

Promoters (% Holding)

39.91%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

60.09%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.00%

About Eiko Lifesciences Ltd.

Founded 1977

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Asian Paints Ltd. 2,57,947.47 2,692.00 2,115.00 - 2,115.00
Solar Industries India Ltd. 1,67,050.52 18,400.00 11,646.00 - 11,646.00
Pidilite Industries Ltd. 1,59,324.90 1,560.55 1,259.00 - 1,259.00
SRF Ltd. 85,634.17 2,888.90 2,355.00 - 2,355.00
Coromandel International Ltd. 59,926.69 2,012.00 1,706.50 - 1,706.50
Berger Paints India Ltd. 57,565.56 495.50 391.10 - 391.10
The Fertilisers And Chemicals Travancore Ltd. 53,965.80 832.00 652.10 - 652.10
UPL Ltd. 52,034.60 616.40 563.15 - 563.15
Gujarat Fluorochemicals Ltd. 45,613.56 4,144.00 2,916.60 - 2,916.60
Godrej Industries Ltd. 44,979.72 1,328.60 744.20 - 744.20
no-content No Records Found

Latest News

May
27
2026
EQUITY Posted on May 27th 2026

Eiko Lifesciences informs about newspaper publication

Pursuant to Regulations 30 and 47 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, Eiko Lifesciences has enclosed a copy of newspaper publication in the following newspapers dated 27th May, 2026 with respect to Audited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Year ended 31st March, 2026 approved at the meeting of Board of Directors held on Tuesday, 26th May, 2026: 1. Mumbai Lakshadeep (Marathi), 2. Financial Express (English). Copy of the results are also uploaded on the website of the Company - www.eikolifesciences.com.
The above information is a part of company’s filings submitted to BSE.
Read More
May
26
2026
EQUITY Posted on May 26th 2026

Eiko Lifesciences informs about change in management

Eiko Lifesciences has informed that based on the recommendation of the Audit Committee, the Board of Directors of the Company has at its Meeting held today i.e. on 26th May, 2026, has approved the appointment of NP Rajput & Co as Internal Auditor for FY 2026-27. Disclosure of information pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026 (‘SEBI Circular’) is attached as Annexure-A.
The above information is a part of company’s filings submitted to BSE. 
Read More
Jul
18
2026
EQUITY Posted on Jul 18th 2026

Chemplast Sanmar informs about disruptions of operations

Chemplast Sanmar has informed that there was minor fire incident on the morning of July 17, 2026 at about 10.30 AM at one of its plants, Ethylene-Di-Chloride (EDC) manufacturing plant of its Karaikal facility- Puducherry. No one was injured and there are no casualties. The impact of the fire incident is being assessed on the equipment, instruments, and electrical installation in the EDC plant. The Company is taking all necessary measures to restore operations at the EDC plant at the earliest and will provide further updates as and when material developments occur. The details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Para B (6) of Part A of Schedule III thereof and SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026 is enclosed as Annexure – A.

The above information is a part of company’s filings submitted to BSE. 

Read More
Jul
18
2026
EQUITY Posted on Jul 18th 2026

Gujarat Narmada Valley Fertilizers & Chemicals informs about board meeting

Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gujarat Narmada Valley Fertilizers & Chemicals has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 05, 2026, to approve the Unaudited Financial Results for the first quarter ended on June 30, 2026. With reference to its earlier letter dated June 25, 2026 intimating closure of trading window and as per Code of Conduct for prevention of Insider Trading in the securities of the Company (‘Code’) read with Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, ‘Trading Window’ for dealing in the securities of the Company shall remain closed for all Designated Persons as defined in the Code and will be opened 48 hours after the declaration of Unaudited Financial Results for the first quarter ended on June 30, 2026. Dealings involving the purchase or sale of the Company's shares by the designated / connected persons of the Company, including their relatives during the window closure period is prohibited.

The above information is a part of company’s filings submitted to BSE. 

Read More
Jul
18
2026
EQUITY Posted on Jul 18th 2026

Polson informs about voting results

Polson has informed that it submitted the voting results along with scrutinizer's report of the postal ballot.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Eiko Lifesciences Ltd. ?

The current share price of Eiko Lifesciences Ltd. is ₹49.67 as of 2026-07-17.

The market capitalisation of Eiko Lifesciences Ltd. is ₹71.26 as of 2026-07-17.

The 1-year return of Eiko Lifesciences Ltd. is -2.87% as of 2026-07-17.

The P/E ratio of Eiko Lifesciences Ltd. is 34.20 as of 2026-07-18.

The 52-week high and low of Eiko Lifesciences Ltd. are ₹64.44 and ₹45.90, respectively, as of 2026-07-17.

The dividend yield of Eiko Lifesciences Ltd. is 0.0% as of2026-07-17.

You can buy Eiko Lifesciences Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Eiko Lifesciences Ltd. is .

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore